SVP Clinical Development Jeffrey Wiezorek sold $76K of Kite Pharma, Inc.

Sold$76,134

$50.76Price

1,500Shares

−5%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Thu, Dec 1. Filed Mon, Dec 5, 2:03 PM ET, during the session. Not investment advice.